Quick Answer
Autonomix Medical, Inc. reported Cash and Equivalents of $9.14 million for fiscal year 2025.
Autonomix Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $9.14M | +6.1% |
| 2024 | $8.61M | +895.1% |
| 2023 | $865.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $9.93M | -16.0% | +32.9% |
| September 30, 2025 | $7.48M | +45.0% | -12.9% |
| June 30, 2025 | $8.59M | +27.2% | -6.0% |
| March 31, 2025 | $9.14M | +6.1% | -22.7% |
| December 31, 2024 | $11.82M | — | +129.4% |
| September 30, 2024 | $5.16M | — | -23.6% |
| June 30, 2024 | $6.75M | — | -21.6% |
| March 31, 2024 | $8.61M | — | — |
- Autonomix Medical, Inc. showed an increase of +6.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Autonomix Medical, Inc.’s cash and equivalents has grown by 956.2% (from $865.0 thousand to $9.14 million).
- The most recent figure is from Autonomix Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: